BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 19624844)

  • 21. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
    Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
    Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of toll-like receptors in systemic lupus erythematosus.
    Rahman AH; Eisenberg RA
    Springer Semin Immunopathol; 2006 Oct; 28(2):131-43. PubMed ID: 17047954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.
    Kang HK; Ecklund D; Liu M; Datta SK
    Arthritis Res Ther; 2009; 11(2):R59. PubMed ID: 19405952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of the type I interferon receptor protects mice from experimental lupus.
    Nacionales DC; Kelly-Scumpia KM; Lee PY; Weinstein JS; Lyons R; Sobel E; Satoh M; Reeves WH
    Arthritis Rheum; 2007 Nov; 56(11):3770-83. PubMed ID: 17968932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.
    Umiker BR; Andersson S; Fernandez L; Korgaokar P; Larbi A; Pilichowska M; Weinkauf CC; Wortis HH; Kearney JF; Imanishi-Kari T
    Eur J Immunol; 2014 May; 44(5):1503-16. PubMed ID: 24500834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE.
    Saito K; Kukita K; Kutomi G; Okuya K; Asanuma H; Tabeya T; Naishiro Y; Yamamoto M; Takahashi H; Torigoe T; Nakai A; Shinomura Y; Hirata K; Sato N; Tamura Y
    Eur J Immunol; 2015 Jul; 45(7):2028-41. PubMed ID: 25871979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression.
    Han JH; Umiker BR; Kazimirova AA; Fray M; Korgaonkar P; Selsing E; Imanishi-Kari T
    Eur J Immunol; 2014 Jan; 44(1):215-26. PubMed ID: 24105635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.
    Bossaller L; Christ A; Pelka K; Nündel K; Chiang PI; Pang C; Mishra N; Busto P; Bonegio RG; Schmidt RE; Latz E; Marshak-Rothstein A
    J Immunol; 2016 Aug; 197(4):1044-53. PubMed ID: 27354219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.
    Guiducci C; Tripodo C; Gong M; Sangaletti S; Colombo MP; Coffman RL; Barrat FJ
    J Exp Med; 2010 Dec; 207(13):2931-42. PubMed ID: 21115693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
    Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
    Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
    Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
    J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
    Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
    J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.
    Stoehr AD; Schoen CT; Mertes MM; Eiglmeier S; Holecska V; Lorenz AK; Schommartz T; Schoen AL; Hess C; Winkler A; Wardemann H; Ehlers M
    J Immunol; 2011 Sep; 187(6):2953-65. PubMed ID: 21859955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.
    Guiducci C; Gong M; Xu Z; Gill M; Chaussabel D; Meeker T; Chan JH; Wright T; Punaro M; Bolland S; Soumelis V; Banchereau J; Coffman RL; Pascual V; Barrat FJ
    Nature; 2010 Jun; 465(7300):937-41. PubMed ID: 20559388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.
    Palafox Sánchez CA; Satoh M; Chan EK; Carcamo WC; Muñoz Valle JF; Orozco Barocio G; Oregon Romero E; Navarro Hernández RE; Salazar Páramo M; Cabral Castañeda A; Vázquez Del Mercado M
    Arthritis Res Ther; 2009; 11(1):R27. PubMed ID: 19232124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    Martín-Márquez BT; Satoh M; Hernández-Pando R; Martínez-García EA; Petri MH; Sandoval-García F; Pizano-Martinez O; García-Iglesias T; Corona-Meraz FI; Vázquez-Del Mercado M
    PLoS One; 2021; 16(10):e0259114. PubMed ID: 34705865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
    Zhang M; Yao C; Cai J; Liu S; Liu XN; Chen Y; Wang S; Ji P; Pan M; Kang Z; Wang Y
    J Transl Med; 2019 Jan; 17(1):37. PubMed ID: 30670047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes.
    Murakami Y; Fukui R; Tanaka R; Motoi Y; Kanno A; Sato R; Yamaguchi K; Amano H; Furukawa Y; Suzuki H; Suzuki Y; Tamura N; Yamashita N; Miyake K
    Front Immunol; 2021; 12():777197. PubMed ID: 34868046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.
    Jackson SW; Scharping NE; Kolhatkar NS; Khim S; Schwartz MA; Li QZ; Hudkins KL; Alpers CE; Liggitt D; Rawlings DJ
    J Immunol; 2014 May; 192(10):4525-32. PubMed ID: 24711620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.